澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

IMMUTEP LTD

0.045

-0.002-4.26%

成交量：1,838.87萬

成交額：83.71萬

市值：6,631.75萬

市盈率：-0.83

高：0.048

開：0.046

低：0.044

收：0.047

52周最高：0.470

52周最低：0.028

股本：14.74億

流通股本：12.28億

量比：0.99

換手率：1.50%

股息：- -

股息率：- -

每股收益(TTM):-0.054

每股收益(LYR):-0.054

淨資產收益率：-77.31%

總資產收益率：-42.45%

市淨率：1.08

市盈率(LYR):-0.83

資料載入中...

總覽公司新聞資訊公告

概念

醫藥生物股+1.18%

資金流向

資金流入：

資金流出：

新聞資訊

Immutep公布一線非小細胞肺癌臨床進展：INSIGHT-003研究成熟總生存期數據積極，TACTI-004研究同步更新

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/IMM.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMM.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMM.AU\",,,,,undefined,":{"symbol":"IMM.AU","market":"AU","secType":"STK","nameCN":"IMMUTEP LTD","latestPrice":0.045,"timestamp":1789452720000,"preClose":0.047,"halted":0,"volume":18388738,"delay":0,"changeRate":-0.04255319148936174,"nameEN":"IMMUTEP LTD","floatShares":1228247159,"shares":1473721306,"eps":-0.0539,"marketStatus":"未開盤","change":-0.002,"latestTime":"09-15 16:12:00 AEST","open":0.046,"high":0.048,"low":0.044,"amount":837144,"amplitude":0.085106,"askPrice":0.047,"askSize":169525,"bidPrice":0.041,"bidSize":460015,"shortable":3,"etf":0,"ttmEps":-0.0539,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.047,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":0.986352,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMM.AU","preClose":0.047,"auctionPrice":0.045,"auctionVolume":455018,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452613762}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMM.AU\",,,,,undefined,":{"symbol":"IMM.AU","floatShares":1228247159,"roa":"-42.45%","roe":"-77.31%","lyrEps":-0.0539,"volumeRatio":0.986352,"shares":1473721306,"dividePrice":0,"high":0.048,"amplitude":0.085106,"preClose":0.047,"low":0.044,"week52Low":0.028,"pbRate":"1.08","psRate":"3.33","week52High":0.47,"institutionHeld":0,"latestPrice":0.045,"committee":0.461432,"eps":-0.0539,"divideRate":0,"volume":18388738,"delay":0,"ttmEps":-0.0539,"open":0.046,"prevYearClose":0.415,"prevWeekClose":0.056,"prevMonthClose":0.048,"prevQuarterClose":0.053,"fiveDayClose":0.047,"twentyDayClose":0.053,"sixtyDayClose":0.052,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMM.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-06-05","symbol":"IMM.AU","defaultRemindTime":1717545600000,"type":"split","dateTimestamp":1717509600000,"forFactor":948148,"toFactor":1000000,"ratio":0.9481480000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMM.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMM.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1142240576","title":"Immutep公布一線非小細胞肺癌臨床進展：INSIGHT-003研究成熟總生存期數據積極，TACTI-004研究同步更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1142240576","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142240576?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 20:02","pubTimestamp":1783944153,"startTime":"0","endTime":"0","summary":"Immutep公司近日发布了一线非小细胞肺癌治疗领域的重要临床更新。其中，INSIGHT-003研究的成熟总生存期数据呈现出积极信号，同时，TACTI-004研究也提供了最新进展。INSIGHT-003研究旨在评估Immutep核心候选药物与标准疗法联合用于一线治疗的效果。这项研究评估了另一种联合治疗方案在特定非小细胞肺癌患者群体中的疗效与安全性。这两项研究的积极进展，标志着Immutep在肿瘤免疫治疗领域，特别是一线非小细胞肺癌这一巨大未满足需求的适应症上，取得了阶段性成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IMM.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"醫藥生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.011805}]}}